HIGHLIGHTS
- who: David Arango and colleagues from the Department of Biomedical Engineering, Universidad los Andes, Bogotá, Colombia have published the Article: Understanding the Potential of Genome Editing in Parkinson’s Disease, in the Journal: (JOURNAL)
- what: Far, this approach has been the only physical delivery method used for in_vivo testing of CRISPR systems .
- how: In a study performed by Ye-Han et_al AAV gene silencing vectors were designed to determine SNCA silencing's efficiency and specificity against human α-syn (hSNCA) . These results indicated that the nanocomposites had significantly neuroprotective effects in motor and non . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.